E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT01332266 · COMPLETED
Trial details
- NCT number
- NCT01332266
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-19
- Primary completion
- 2016-01-31
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.